DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01683292 (ClinicalTrials.gov)	January 2006	7/9/2012	Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's Disease	An Ascending-Dose, Single-Centre Study Investigating the Safety, Tolerability, Efficacy, and Pharmacokinetics of VR040(Inhaled Apomorphine)in Parkinson's Disease	Parkinson's Disease	Drug: Inhaled VR040;Drug: Placebo for VR040	South Glasgow University Hospitals NHS Trust	Vectura Limited	Completed	30 Years	N/A	Both	29	Phase 2	United Kingdom

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT01683292
(ClinicalTrials.gov)

January 2006

7/9/2012

Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's Disease

An Ascending-Dose, Single-Centre Study Investigating the Safety, Tolerability, Efficacy, and Pharmacokinetics of VR040(Inhaled Apomorphine)in Parkinson's Disease

Parkinson's Disease

Drug: Inhaled VR040;Drug: Placebo for VR040

South Glasgow University Hospitals NHS Trust

Vectura Limited

Completed

30 Years

N/A

Both

Phase 2

United Kingdom